Ticker
PYXSCompany Name
PYXIS ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Invested Capital | Net Income Common Stock | Return on Invested Capital |
---|---|---|---|
6/30/2025 | $ 107.11M | $ -96.29M | -89.9% |
3/31/2025 | $ 122.94M | $ -95.23M | -77.46% |
12/31/2024 | $ 140.95M | $ -77.33M | -54.86% |
9/30/2024 | $ 174.22M | $ -57.36M | -32.92% |
6/30/2024 | $ 190.67M | $ -59.2M | -31.05% |
3/31/2024 | $ 204.94M | $ -57.8M | -28.21% |
12/31/2023 | $ 147.03M | $ -73.79M | -50.19% |
9/30/2023 | $ 159.56M | $ -94.29M | -59.09% |
6/30/2023 | $ 166.53M | $ -98.92M | -59.4% |
3/31/2023 | $ 172.41M | $ -108.58M | -62.98% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Inv. Capital
(=) ROIC
ROIC for PYXIS ONCOLOGY INC is calculated as follows: Net Inc. Cmn. [ $ -12.83M ] / Inv. Capital [ $ -14.87M ]
(=) ROIC [ 0% ]
Minimum
Jun 30, 2025
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.36K |
---|---|
min | -46.36% |
max | 48.66% |
average | 0.68% |
median | 3.38% |
std | 15.2% |